Principal Securities’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-545
Closed -$30.3K 3286
2025
Q3
$30.3K Buy
545
+124
+29% +$6.64K ﹤0.01% 2216
2025
Q2
$21.7K Buy
421
+135
+47% +$6.78K ﹤0.01% 2271
2025
Q1
$20.6K Hold
286
﹤0.01% 2184
2024
Q4
$20.6K Buy
286
+92
+47% +$6.76K ﹤0.01% 2180
2024
Q3
$15.5K Buy
194
+55
+40% +$4.13K ﹤0.01% 2249
2024
Q2
$9.96K Buy
139
+13
+10% +$957 ﹤0.01% 2399
2024
Q1
$8.87K Buy
126
+14
+13% +$1K ﹤0.01% 2388
2023
Q4
$8.64K Buy
+112
New +$7.38K ﹤0.01% 2318

Other funds holding TECH

Principal Securities's TECH Position: Q4 2025 in Review

Principal Securities sold out of Bio-Techne (TECH) in Q4 2025, closing a stake of 545 shares — an estimated $30.3K sold.

Principal Securities first reported a position in TECH in Q4 2023 and held it in 8 quarters. The position peaked at $30.3K in Q3 2025. 584 funds tracked by Wall St. Rank hold TECH as of Q4 2025.

  • Principal Securities reported no remaining Bio-Techne position as of Q4 2025 after selling out during the quarter.
  • Principal Securities sold 545 Bio-Techne shares in Q4 2025, an estimated $30.3K.
  • Principal Securities first reported a position in Bio-Techne in Q4 2023 and held it in 8 quarters.
  • Principal Securities's Bio-Techne position peaked at $30.3K in Q3 2025.
  • 584 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2025.

Based on Principal Securities's 13F filing for Q4 2025, filed 12 Feb 2026.